CD36 and type 2 diabetes mellitus: MDMs from T2D patients retrieved from the M.tb stimulation assay 1 and 3 days p.i. also had reduced frequencies of CD36 expressing cells compared to cells from no-T2D controls, reaching statistical significance at D3 (supplementary figure S7).